参考文献/References:
[1] Reinstadler SJ,Klug G,Feistritzer HJ,et al. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction[J]. Eur Heart J Cardiovasc Imaging,2016;17(2):169-176.
[2] Murray CJ,Barber RM,Foreman KJ,et al. Global,regional,and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries,1990-2013: quantifying the epidemiological transition[J]. Lancet,2015,386(10009):2145-2191.
[3] Virani SS,Alonso A,Benjamin EJ,et al. Heart Disease and stroke statistics-2020 update: a report from the american heart association[J]. Circulation,2020,141(9):e139-e596.
[4] Zhao D,Liu J,Wang M,et al. Epidemiology of cardiovascular disease in China: current features and implications[J]. Nat Rev Cardiol,2019,16(4):203-212.
[5] Murray CJ,Vos T,Lozano R,et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions,1990-2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet,2012,380(9859):2197-2223.
[6] Reinstadler SJ,Stiermaier T,Eitel C,et al. Antecedent hypertension and myocardial injury in patients with reperfused ST-elevation myocardial infarction[J]. J Cardiovasc Magn Reson,2016;18(1):80.
[7] Vidal-Petiot E,Ford I,Greenlaw N,et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study[J]. Lancet,2016,388(10056):2142-2152.
[8] Bohm M,Schumacher H,Teo KK,et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials[J]. Lancet,2017,389(10085):2226-2237.
[9] Rabkin SW,Shiekh IA,Wood DA. The impact of left ventricular mass on diastolic blood pressure targets for patients with coronary artery disease[J]. Am J Hypertens,2016,29(9):1085-1093.
[10] Whelton SP,Mcevoy JW,Shaw L,et al. Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors[J]. JAMA Cardiol,2020;5(9):1011-1018.
[11] Hansson L,Zanchetti A,Carruthers SG,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group[J]. Lancet,1998,351(9118):1755-1762.
[12] Flint AC,Conell C,Ren X,et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes[J]. N Engl J Med,2019,381(3):243-251.
[13] Harbaoui B,Courand PY,Lantelme P. High pulse pressure: complex PCI or complex patients?[J]. J Am Coll Cardiol,2019,74(15):2012.
[14] Franklin SS,Wong ND. Pulse pressure: how valuable as a diagnostic and therapeutic tool?[J]. J Am Coll Cardiol,2016;67(4):404-406.
[15] Selvaraj S,Steg PG,Elbez Y,et al. Pulse pressure and risk for cardiovascular events in patients with atherothrombosis: from the REACH registry[J]. J Am Coll Cardiol,2016,67(4):392-403.
[16] Bakris GL,Laffin LJ. Assessing wide pulse pressure hypertension: data beyond the guidelines[J]. J Am Coll Cardiol,2019,73(22):2856-2858.
[17] Bavishi C,Goel S,Messerli FH. Isolated systolic hypertension: an update after SPRINT[J]. Am J Med,2016,129(12):1251-1258.
[18] Harbaoui B,Nanchen D,Lantelme P,et al. Prognostic value of pulse pressure after an acute coronary syndrome[J]. Atherosclerosis,2018,277:219-226.
[19] Roman MJ,Devereux RB,Kizer JR,et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study[J]. Hypertension,2007,50(1):197-203.
[20] Franklin SS,Gokhale SS,Chow VH,et al. Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study[J]. Hypertension,2015,65(2):299-305.
[21] Sanidas E,Grassos C,Papadopoulos DP,et al. Labile hypertension: a new disease or a variability phenomenon?[J]. J Hum Hypertens,2019,33(6):436-443.
[22] Stevens SL,Wood S,Koshiaris C,et al. Blood pressure variability and cardiovascular disease:systematic review and meta-analysis[J]. BMJ,2016,354:i4098.
[23] Gosmanova EO,Mikkelsen MK,Molnar MZ,et al. Association of systolic blood pressure variability with mortality,coronary heart disease,stroke,and renal disease[J]. J Am Coll Cardiol,2016,68(13):1375-1386.
[24] Hassan A,Abd-El RH,Mohsen K,et al. Impact of in-hospital blood pressure variability on cardiovascular outcomes in patients with acute coronary syndrome[J]. J Clin Hypertens (Greenwich),2017,19(12):1252-1259.
[25] Palatini P,Reboldi G,Beilin LJ,et al. Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: the Ambulatory Blood Pressure-International Study[J]. Hypertension,2014,64(3):487-493.
[26] Muntner P,Whittle J,Lynch A I,et al. Visit-to-visit variability of blood pressure and coronary heart disease,stroke, heart failure ,and mortality: a cohort study[J]. Ann Intern Med,2015,163(5):329-338.
[27] Mezue K,Goyal A,Pressman GS,et al. Blood pressure variability predicts adverse events and cardiovascular outcomes in chronic kidney disease: a Post-Hoc analysis of the SPRINT trial[J]. Am J Hypertens,2017,31(1):48-52.
[28] Yu S,Zhou Y,Wu K,et al. Association of interarm blood pressure difference with cardio-cerebral vascular disease: a community-based,cross-sectional study[J]. J Clin Hypertens (Greenwich),2019,21(8):1115-1123.
[29] Clark CE,Taylor RS,Shore AC,et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis[J]. Lancet,2012,379(9819):905-914.
[30] Hsu PC,Lee WH,Tsai WC,et al. Usefulness of four-limb blood pressure measurement in prediction of overall and cardiovascular mortality in acute myocardial infarction[J]. Int J Med Sci,2020,17(10):1300-1306.
[31] Rahman F,Al RM,Blaha MJ,et al. Relation of diastolic blood pressure and coronary artery calcium to coronary events and outcomes (from the multi-ethnic study of atherosclerosis)[J]. Am J Cardiol,2017,120(10):1797-1803.
[32] Sheng CS,Liu M,Zeng WF,et al. Four-limb blood pressure as predictors of mortality in elderly Chinese[J]. Hypertension,2013,61(6):1155-1160.
[33] Chen HY,Wei F,Wang LH,et al. Abnormal ankle-brachial index and risk of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis[J]. J Nephrol,2017,30(4):493-501.
[34] Lin JS,Olson CM,Johnson ES,et al. The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force[J]. Ann Intern Med,2013,159(5):333-341.
[35] Attar R,Wester A,Koul S,et al. Peripheral artery disease and outcomes in patients with acute myocardial infarction[J]. Open Heart,2019,6(1):e1004.
[36] Velescu A,Clara A,Marti R,et al. Abnormally high ankle-brachial index is associated with all-cause and cardiovascular mortality: the REGICOR study[J]. Eur J Vasc Endovasc Surg,2017,54(3):370-377.
[37] Jones WS,Patel MR,Rockman CB,et al. Association of the ankle-brachial index with history of myocardial infarction and stroke[J]. Am Heart J,2014,167(4):499-505.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(6):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(6):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(6):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(6):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(6):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(6):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]